0001022079-18-000008.txt : 20180126 0001022079-18-000008.hdr.sgml : 20180126 20180126164307 ACCESSION NUMBER: 0001022079-18-000008 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180124 FILED AS OF DATE: 20180126 DATE AS OF CHANGE: 20180126 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Doherty Catherine T. CENTRAL INDEX KEY: 0001520897 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12215 FILM NUMBER: 18552454 MAIL ADDRESS: STREET 1: C/O QUEST DIAGNOSTICS STREET 2: 500 PLAZA DRIVE CITY: SECAUCUS STATE: NJ ZIP: 07094 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: QUEST DIAGNOSTICS INC CENTRAL INDEX KEY: 0001022079 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 161387862 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 500 PLAZA DRIVE CITY: SECAUCUS STATE: NJ ZIP: 07094 BUSINESS PHONE: 9735202700 MAIL ADDRESS: STREET 1: 500 PLAZA DRIVE CITY: SECAUCUS STATE: NJ ZIP: 07094 FORMER COMPANY: FORMER CONFORMED NAME: CORNING CLINICAL LABORATORIES INC DATE OF NAME CHANGE: 19960903 4 1 wf-form4_151700297271754.xml FORM 4 X0306 4 2018-01-24 0 0001022079 QUEST DIAGNOSTICS INC DGX 0001520897 Doherty Catherine T. 500 PLAZA DRIVE SECAUCUS NJ 07094 0 1 0 0 SVP, Group Exec. Clin. Fran. Common Stock 2018-01-24 4 M 0 21294 52.165 A 90709 D Common Stock 2018-01-24 4 S 0 21294 104 D 69415 D Common Stock 3834 I 401(k)/SDCP Stock Options (Right to Buy) 52.165 2018-01-24 4 M 0 21294 52.165 D 2024-02-13 Common Stock 21294.0 0 D This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 27, 2017. These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) and/or Supplemental Deferred Compensation Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under each Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date. The options vested in three equal annual installments beginning with the first on February 13, 2015, the second on February 13, 2016 and the final on February 13, 2017. /s/ Elena H. Radine, Attorney in Fact for Catherine T. Doherty 2018-01-26